vs

Side-by-side financial comparison of Angel Studios, Inc. (ANGX) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $109.9M, roughly 1.8× Angel Studios, Inc.). REPLIGEN CORP runs the higher net margin — 6.7% vs -71.5%, a 78.2% gap on every dollar of revenue. On growth, Angel Studios, Inc. posted the faster year-over-year revenue change (254.3% vs 13.6%).

Angel Studios, Inc. is an American independent media company and film distribution studio based in Provo, Utah. It produces and distributes films for theatrical release and operates the over-the-top video on-demand service Angel. The streaming service is available worldwide and can be accessed via web browsers or via application software installed on smartphones, tablet computers, and smart TVs.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

ANGX vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.8× larger
RGEN
$197.9M
$109.9M
ANGX
Growing faster (revenue YoY)
ANGX
ANGX
+240.6% gap
ANGX
254.3%
13.6%
RGEN
Higher net margin
RGEN
RGEN
78.2% more per $
RGEN
6.7%
-71.5%
ANGX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ANGX
ANGX
RGEN
RGEN
Revenue
$109.9M
$197.9M
Net Profit
$-78.6M
$13.3M
Gross Margin
60.2%
52.5%
Operating Margin
-64.5%
9.0%
Net Margin
-71.5%
6.7%
Revenue YoY
254.3%
13.6%
Net Profit YoY
-111.5%
143.9%
EPS (diluted)
$-0.47
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANGX
ANGX
RGEN
RGEN
Q4 25
$109.9M
$197.9M
Q3 25
$76.5M
$188.8M
Q2 25
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$20.1M
$154.9M
Q2 24
$154.1M
Q1 24
$151.3M
Net Profit
ANGX
ANGX
RGEN
RGEN
Q4 25
$-78.6M
$13.3M
Q3 25
$-38.6M
$14.9M
Q2 25
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-13.9M
$-654.0K
Q2 24
$3.3M
Q1 24
$2.1M
Gross Margin
ANGX
ANGX
RGEN
RGEN
Q4 25
60.2%
52.5%
Q3 25
55.1%
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
59.7%
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
ANGX
ANGX
RGEN
RGEN
Q4 25
-64.5%
9.0%
Q3 25
-49.8%
8.9%
Q2 25
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-75.3%
-5.1%
Q2 24
1.0%
Q1 24
1.3%
Net Margin
ANGX
ANGX
RGEN
RGEN
Q4 25
-71.5%
6.7%
Q3 25
-50.4%
7.9%
Q2 25
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-68.9%
-0.4%
Q2 24
2.2%
Q1 24
1.4%
EPS (diluted)
ANGX
ANGX
RGEN
RGEN
Q4 25
$-0.47
$0.24
Q3 25
$-0.25
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.10
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANGX
ANGX
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$44.1M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$-25.8M
$2.1B
Total Assets
$241.4M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANGX
ANGX
RGEN
RGEN
Q4 25
$44.1M
$767.6M
Q3 25
$63.3M
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
ANGX
ANGX
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ANGX
ANGX
RGEN
RGEN
Q4 25
$-25.8M
$2.1B
Q3 25
$37.2M
$2.1B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$-5.0M
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
ANGX
ANGX
RGEN
RGEN
Q4 25
$241.4M
$2.9B
Q3 25
$197.0M
$2.9B
Q2 25
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$13.5M
$2.8B
Q2 24
$2.9B
Q1 24
$2.8B
Debt / Equity
ANGX
ANGX
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANGX
ANGX
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANGX
ANGX
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$-58.1M
$48.1M
Q2 25
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$-37.7M
$49.3M
Q2 24
$42.2M
Q1 24
$44.7M
Free Cash Flow
ANGX
ANGX
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
ANGX
ANGX
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
ANGX
ANGX
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
ANGX
ANGX
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANGX
ANGX

Licensed content and other revenue$109.8M100%
Pay it Forward revenue$163.7K0%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons